Manuel Rieber
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Protease and Inhibitor Mechanisms
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
Papers in
-
- Cell Adhesion Molecules Research 11
- Oncology 22
- Cancer-related Molecular Pathways 17
- Co-authors
- MARY STRASBERG RIEBER (34 shared papers)Ana M. Mendes‐Pereira (1 shared paper)T Imaeda (4 shared papers)Egidio L Romano (1 shared paper)Atilio I. Anzellotti (1 shared paper)Roberto A. Sánchez‐Delgado (1 shared paper)Renée Lira (3 shared papers)José Domingo Medina (2 shared papers)
- Journals
- International Journal of Cancer (14 papers)Biochemical and Biophysical Research Communications (11 papers)Cancer Biology & Therapy (5 papers)DNA and Cell Biology (3 papers)Biochemical Pharmacology (3 papers)
- Partner nations
- VenezuelaUnited States
In The Last Decade
Manuel Rieber
68 papers receiving 724 citations
Peers
Comparison fields: 5 of 88
- Cancer Research 153
- Immunology and Allergy 63
- Oncology 219
- Molecular Biology 440
- Biotechnology 55
Countries citing papers authored by Manuel Rieber
This map shows the geographic impact of Manuel Rieber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Rieber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Rieber more than expected).
Fields of papers citing papers by Manuel Rieber
This network shows the impact of papers produced by Manuel Rieber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Rieber. The network helps show where Manuel Rieber may publish in the future.
Co-authors
The 19 scholars most cited alongside Manuel Rieber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 44 | |
| 2 | 1981 | 43 | |
| 3 | 1998 | 43 | |
| 4 | 2005 | 42 | |
| 5 | 2005 | 36 | |
| 6 | 2020 | 28 | |
| 7 | 2003 | 27 | |
| 8 | 2012 | 26 | |
| 9 | 2004 | 25 | |
| 10 | 2015 | 25 | |
| 11 | 2000 | 21 | |
| 12 | 1974 | 20 | |
| 13 | 2009 | 20 | |
| 14 | 1989 | 19 | |
| 15 | 2014 | 16 | |
| 16 | 2011 | 16 | |
| 17 | Cyclin-dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B16 melanoma terminal differentiation. | 1994 | 15 |
| 18 | 2019 | 15 | |
| 19 | Transformation-dependent modifications in released and cell-bound surface proteins detected by antisera to shed antigens. | 1976 | 14 |
| 20 | 1998 | 14 |
About Manuel Rieber
Manuel Rieber is a scholar working on Immunology and Allergy, Oncology, Molecular Biology, Biotechnology and Cell Biology, having authored 71 papers that have together received 766 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (17 papers), Cell Adhesion Molecules Research (11 papers), RNA Interference and Gene Delivery (10 papers), Cancer Research and Treatments (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Ubiquitin and proteasome pathways (6 papers), Glycosylation and Glycoproteins Research (6 papers) and Cell death mechanisms and regulation (6 papers). The work is most often cited by research in Cancer Research (153 citations), Immunology and Allergy (63 citations), Oncology (219 citations), Molecular Biology (440 citations) and Biotechnology (55 citations). Manuel Rieber has collaborated with scholars based in Venezuela and United States. Frequent co-authors include MARY STRASBERG RIEBER, Ana M. Mendes‐Pereira, T Imaeda, Egidio L Romano, Atilio I. Anzellotti, Roberto A. Sánchez‐Delgado, Renée Lira, José Domingo Medina, Italo Mario Cesari and Luis Alberto Gómez. Their work appears in journals such as International Journal of Cancer, Biochemical and Biophysical Research Communications, Cancer Biology & Therapy, DNA and Cell Biology and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.